VITALITY BIOPHARMA ADOPTS NEW NAME – MALACHITE INNOVATIONS, INC.

New Corporate Name Reflects Company’s Expanded Business Strategy, Corporate...

read more
VITALITY BIOPHARMA ANNOUNCES EFFECTIVE S-1 REGISTRATION STATEMENT AND DTC ELIGIBILITY

CLEVELAND, OHIO – (September 2, 2021) – Vitality Biopharma, Inc. (OTC Mkts:...

read more
VITALITY BIOPHARMA ENTERS INTO $5 MILLION EQUITY LINE FINANCING RELATIONSHIP WITH INSTITUTIONAL INVESTOR

CLEVELAND, OHIO – (August 20, 2021) – Vitality Biopharma, Inc. (VBIO)...

read more
FDA GRANTS VITALITY BIOPHARMA ORPHAN DRUG DESIGNATION FOR VBX-100 PRODRUG

CLEVELAND, OHIO – (August 10, 2021) – Vitality Biopharma, Inc. (VBIO)...

read more
CEO LETTER TO SHAREHOLDERS

To the Shareholders of Vitality Biopharma, Inc.: In October 2018, Vitality...

read more
VITALITY BIOPHARMA RETAINS DELMORGAN & CO. TO EXPLORE STRATEGIC ALTERNATIVES

CLEVELAND, OHIO – (September 25, 2020) – Vitality Biopharma, Inc. (OTCQB:...

read more
VITALITY BIOPHARMA BOARD UPDATE

CLEVELAND, OHIO – (April 27, 2020) — Vitality Biopharma, Inc. (Ticker:...

read more
VITALITY BIOPHARMA WELCOMES NEW EXECUTIVE MANAGEMENT TEAM

– Appointment of Current Director Michael Cavanaugh as Interim Chief...

read more
VITALITY BIOPHARMA CO-FOUNDER DR. AVTAR DHILLON RESIGNS FROM BOARD OF DIRECTORS

LOS ANGELES, CA – (April 25, 2019) — Vitality Biopharma, Inc. (Ticker:...

read more
VITALITY BIOPHARMA APPOINTS FORMER OHIO GOVERNOR RICHARD F. CELESTE TO BOARD

LOS ANGELES, Jan. 24, 2019 — Vitality Biopharma, Inc. (Ticker: VBIO)...

read more
VITALITY BIOPHARMA ANNOUNCES CORPORATE UPDATES AND COMPLETION OF AN SEC EXAMINATION

Company appoints two new directors including the Hon. Edward Feighan as new...

read more